Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Bionik Laboratories Corp. (BNKL) had Return on Tangible Equity of 76.45% for the most recently reported fiscal quarter, ending 2023-03-31.
| Income Statement Financials | |
$0.50M |
|
$-1.36M |
|
$0.25M |
|
$0.25M |
|
$1.80M |
|
$-1.30M |
|
$-0.07M |
|
$-1.36M |
|
$-1.36M |
|
$-1.36M |
|
$-1.36M |
|
$-1.36M |
|
$-1.36M |
|
$-1.30M |
|
$-1.28M |
|
6.90M |
|
6.90M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$2.78M |
|
$0.19M |
|
$0.58M |
|
$3.36M |
|
$2.31M |
|
$2.16M |
|
$2.69M |
|
$5.00M |
|
$-1.64M |
|
$-1.77M |
|
$-1.64M |
|
6.99M |
|
| Cash Flow Statement Financials | |
$-3.39M |
|
$-0.22M |
|
$2.05M |
|
$1.99M |
|
$0.43M |
|
$-1.56M |
|
$0.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.20 |
|
-- |
|
-- |
|
4.18 |
|
-1.31 |
|
50.71% |
|
-258.85% |
|
-258.85% |
|
-- |
|
-270.66% |
|
-270.66% |
|
$-3.39M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.24 |
|
1.11 |
|
81.37 |
|
82.67% |
|
|
Return on Tangible Equity |
76.45% |
-40.34% |
|
-263.25% |
|
$-0.23 |
|
$-0.49 |
|
$-0.49 |
|